OncoSil Medical LtdASX: OSL

OncoSil PanCO Clinical Trial Presented At ESMO World WCGIC

· Issued by OncoSil Medical Ltd

Filed with ASX · · 2 pages · English

Sydney, Australia, 29 June 2022:OncoSil Medical Limited (ASX: OSL) (OncoSilor theCompany) is pleased to announce that the Principal Investigator of the PanCO study will be presenting both an oral and poster presentation at the ESMO World Congress on Gastrointestinal Cancer (WCGIC) on 29 June 2022. The presentation is titled “Comparison of resected vs. non-resected patients with unresectable locall

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases